Adamas Pharmaceuticals (United States)
- Research works
- 108 ▼ 13% vs 2018-21
- Citations
- 11k 105.9 per fractional work
- Top-10% rate
- 11.7% all institutions 10.0%
- Open access
- 30% world 40%
- International
- 23% world 18%
Not ranked overall: Adamas Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Adamas Pharmaceuticals (United States) work in?
In all years, 41% of research at Adamas Pharmaceuticals (United States) is in Life Sciences, 36% in Health Sciences. Its largest fields are Medicine (34%), Biochemistry, Genetics and Molecular Biology (30%), Immunology and Microbiology (7%). It does 2.5× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 24 fields, with their numbers
- Life Sciences4541.4%
- Health Sciences3936.4%
- Medicine3734.2%
- Health Professions21.6%
- Nursing00.4%
- Veterinary00.2%
- Physical Sciences1615.3%
- Environmental Science44.0%
- Engineering43.9%
- Chemistry22.2%
- Materials Science22.2%
- Computer Science10.9%
- Energy10.9%
- Earth and Planetary Sciences10.7%
- Mathematics00.4%
- Physics and Astronomy00.2%
- Social Sciences76.9%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.4×. Every wedge is a field page.
All 14 fields, with their numbers
- Pharmacology, Toxicology and Pharmaceutics5.36×0 works
- Biochemistry, Genetics and Molecular Biology3.64×2 works
- Environmental Science2.74×1 works
- Medicine2.50×4 works
- Psychology1.24×0 works
- Chemistry1.08×0 works
- Immunology and Microbiology0.94×0 works
- Earth and Planetary Sciences0.87×0 works
- Mathematics0.80×0 works
- Materials Science0.54×0 works
- Economics, Econometrics and Finance0.44×0 works
- Neuroscience0.37×0 works
- Engineering0.28×0 works
- Health Professions0.24×0 works
- Pharmacology, Toxicology and Pharmaceutics 5.4×
- Biochemistry, Genetics and Molecular Biology 3.6×
- Environmental Science 2.7×
- Medicine 2.5×
- Psychology 1.2×
- Chemistry 1.1×
- Immunology and Microbiology 0.9×
- Earth and Planetary Sciences 0.9×
- Mathematics 0.8×
- Materials Science 0.5×
- Economics, Econometrics and Finance 0.4×
- Neuroscience 0.4×
- Engineering 0.3×
- Health Professions 0.2×
Who are the top researchers at Adamas Pharmaceuticals (United States)?
Ranked on the quality score, Jack T Nguyen, Gregory T. Went and Rajiv Patni lead among researchers whose main affiliation is Adamas Pharmaceuticals (United States).
- 1
Jack T Nguyen
United States · #335,829 worldwide 6.1k citations · 71 works
- 2
Gregory T. Went
United States · #425,879 worldwide 2.6k citations · 29 works
- 3
Rajiv Patni
United States · #3,519,143 worldwide 723 citations · 30 works
- 4
Reed Johnson
United States · #3,605,993 worldwide 494 citations · 18 works
Which keywords describe research at Adamas Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Immune Response, Cancer, Glycosylation, Cancer Therapy, Monoclonal Antibodies, Inflammation, Antiviral Therapy and Epidemiology.
- HIV
- Quantitative
- Therapy
- Ribosome
- Glycans
- Therapeutics
- Genomic Integration
- Antiretroviral Therapy
- Fc Receptors
- Antibody Engineering
- Drug Discovery
- Neurodegeneration
- Gene Expression
- Antibodies
- Therapeutic Antibodies
- Genomics
- Monoclonal Antibodies
- Cancer Therapy
- Immune Response
- Cancer
- Epidemiology
- Inflammation
- Glycosylation
- Oxidative Stress
- Antiviral Therapy
- Parkinson's Disease
- Vaccine
- Gene Therapy
- Liver Disease
- Transcriptional Regulation
- Virus
- Apoptosis
- Angiogenesis
- Pharmacology
- Mitochondrial Dysfunction
- Cell Signaling
- Immune System
- Translation
- Calcium Signaling
- Cell Migration
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology8▲ 1.79×27 topics
- Cancer7▲ 4.9×17 topics
- Inflammation6▲ 2.6×22 topics
- Immune Response6▲ 9.5×9 topics
- Glycosylation6▲ 23×3 topics
- Cancer Therapy5▲ 7.4×8 topics
- Oxidative Stress5▲ 2.5×15 topics
- Monoclonal Antibodies4▲ 25×3 topics
- Antiviral Therapy4▲ 23×3 topics
- Genomics3▲ 8.9×4 topics
- Parkinson's Disease3▲ 14×6 topics
- Therapeutic Antibodies3▲ 24×2 topics
- Vaccine3▲ 7.5×6 topics
- Antibodies3▲ 33×2 topics
- Gene Therapy3▲ 11×3 topics
- Gene Expression3▲ 4.6×6 topics
- Liver Disease3▲ 20×2 topics
- Neurodegeneration3▲ 8.8×7 topics
- Transcriptional Regulation3▲ 11×6 topics
- Drug Discovery3▲ 6.5×4 topics
- Virus3▲ 21×2 topics
- Antibody Engineering3▲ 24×1 topic
- Apoptosis3▲ 6.2×3 topics
- Fc Receptors3▲ 24×1 topic
- Angiogenesis2▲ 5.7×9 topics
- Antiretroviral Therapy2▲ 10×3 topics
- Pharmacology2▲ 7.0×5 topics
- Genomic Integration2▲ 21×2 topics
- Mitochondrial Dysfunction2▲ 6.2×6 topics
- Therapeutics2▲ 16×2 topics
- Cell Signaling2▲ 6.4×6 topics
- Glycans2▲ 26×1 topic
- Immune System2▲ 6.5×1 topic
- Ribosome2▲ 22×1 topic
- Translation2▲ 10×1 topic
- Therapy2▲ 9.7×3 topics
- Calcium Signaling2▲ 15×2 topics
- Quantitative2▲ 16×2 topics
- Cell Migration2▲ 21×2 topics
- HIV2▲ 15×2 topics
Which research topics does Adamas Pharmaceuticals (United States) publish most on?
By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, Pediatric Pain Management Techniques, Digital Mental Health Interventions and Telemedicine and Telehealth Implementation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 2 Pediatric Pain Management Techniques Pediatrics, Perinatology and Child Health 0 works
- 3 Digital Mental Health Interventions Applied Psychology 0 works
- 4 Telemedicine and Telehealth Implementation Public Health, Environmental and Occupational Health 0 works
- 5 Hydrology and Watershed Management Studies Water Science and Technology 0 works
- 6 Flood Risk Assessment and Management Global and Planetary Change 0 works
- 7 Chronic Lymphocytic Leukemia Research Genetics 0 works
- 8 Pharmacovigilance and Adverse Drug Reactions Toxicology 0 works
- 9 Schizophrenia research and treatment Psychiatry and Mental health 0 works
- 10 Cancer Immunotherapy and Biomarkers Oncology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Adamas Pharmaceuticals (United States)'s research output changed?
Output in 2022-2025 was 13% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Adamas Pharmaceuticals (United States) as a percentage of every work published that year, 0.000032% in 2024.
Fractional works of Adamas Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Emeryville
- Alcohol Research Group
- Ernest Gallo Clinic and Research Center
- Sound Agriculture (United States)
- KineMed (United States)
- Santen (United States)
- CEP America
- Amyris (United States)
- NovaBay Pharmaceuticals (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Adamas Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.